In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Astra paid Merck $820 million for share in Astra Merck Inc.

Executive Summary

Astra paid $820 million to Merck & Co. for a 50% share in the joint venture Astra Merck Inc., previously a unit of Merck known as Astra Merck Group. The venture will market Astra products in the US.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Joint Venture

Related Companies

UsernamePublicRestriction

Register